Showing results (161-170 of 285) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|January 14, 2010
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirinMichelle Martinot-Peignoux, Christiane Stern, Sarah Maylin, et al.
European Journal of Immunology|November 23, 2011
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patientsVivien Béziat, Olav Dalgard, Tarik Asselah, et al.
The American Journal of Gastroenterology|July 6, 2004
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trialPaul J Pockros, Robert Carithers, Paul Desmond, et al.
Hepatology (Baltimore, Md.)|February 1, 2013
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral loadStuart C Gordon, Zahary Krastev, Andrzej Horban, et al.
The New England Journal of Medicine|February 28, 2003
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BPatrick Marcellin, Ting-Tsung Chang, Seng Gee Lim, et al.
Gastroenterology|July 6, 2010
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infectionThomas Berg, Patrick Marcellin, Fabien Zoulim, et al.
Hepatology (Baltimore, Md.)|March 5, 2011
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virusAndrea Snow-Lampart, Brandi Chappell, Maria Curtis, et al.
Hepatology International|May 22, 2016
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failureFabien Zoulim, Jolanta Białkowska-Warzecha, Mircea Mihai Diculescu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 18, 2009
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus reportNabil Antaki, Antonio Craxi, Sanaa Kamal, et al.
Antiviral Therapy|April 12, 2013
Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional studyPatrick Marcellin, Victoria Arama, Hakan Leblebicioglu, et al.
Pageof 29